STAT3 and breast cancer: We and others have previously reported that K685 acetylation is elevated in breast cancer, colon cancer, and melanoma (34, 35), and the acetylation of STAT3 is critical for its dimerization and activation (33), strongly supporting the concept that acetylated STAT3 is a viable therapeutic target.